• 1477 Citations
  • 20 h-Index
1989 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Vito Di Lernia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 29 Similar Profiles
Psoriasis Medicine & Life Sciences
Skin Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Dermatology Medicine & Life Sciences
Nevus Medicine & Life Sciences
Scalp Medicine & Life Sciences
Multicenter Studies Medicine & Life Sciences
Dermoscopy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

  • 1477 Citations
  • 20 h-Index
  • 136 Article
  • 3 Letter
  • 2 Review article
  • 1 Comment/debate
2 Citations (Scopus)

Pruritus characteristics in a large Italian cohort of psoriatic patients

Psocare Registry Network, Jul 1 2019, In : Journal of the European Academy of Dermatology and Venereology. 33, 7, p. 1316-1324 9 p.

Research output: Contribution to journalArticle

Pruritus
Psoriasis
Genitalia
Italy
Autoimmune Diseases

Secukinumab in an HIV-positive patient with psoriasis

Di Lernia, V., Casanova, D. M. & Garlassi, E., Jan 1 2019, In : JDDG - Journal of the German Society of Dermatology.

Research output: Contribution to journalLetter

3 Citations (Scopus)

An overview of the efficacy and safety of systemic treatments for psoriasis in the elderly

Di Lernia, V. & Goldust, M., Aug 3 2018, In : Expert Opinion on Biological Therapy. 18, 8, p. 897-903 7 p.

Research output: Contribution to journalReview article

Geriatrics
LY2439821
Psoriasis
Drug interactions
Safety

Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines

Cutaneous Immunology group of SIDeMaST, Jun 1 2018, In : Giornale Italiano di Dermatologia e Venereologia. 153, 3, p. 305-315 11 p.

Research output: Contribution to journalReview article

Venereology
Bullous Pemphigoid
Dermatology
Guidelines
Blister
3 Citations (Scopus)

Adalimumab for treating childhood plaque psoriasis: a clinical trial evaluation

Di Lernia, V., Aug 23 2017, (Accepted/In press) In : Expert Opinion on Biological Therapy. p. 1-4 4 p.

Research output: Contribution to journalArticle

Psoriasis
Clinical Trials
Methotrexate
Safety
Therapeutics